Edition:
United Kingdom

People: Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

368.15INR
19 Aug 2019
Change (% chg)

-- (--)
Prev Close
Rs368.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,059,250
52-wk High
Rs711.90
52-wk Low
Rs356.20

Munos, Bernard 

Mr. Bernard Munos serves as Non-Executive Independent Director of Glenmark Pharmaceuticals Ltd. Mr. Munos advises organisations on being better innovators. He serves on the advisory council of the National Centre for Advancing Translational Sciences (NCATS), is a member of the National Academy of Medicine’s Forum on Drug R&D and Translation and is an advisor to the journal, Science Translational Medicine. His research on pharmaceutical innovation has been published in Nature and Science, as well as profiled by Forbes magazine.

Basic Compensation

Total Annual Compensation, INR 400,000
Restricted Stock Award, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 400,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Glenn Saldanha

161,620,000

V. S. Mani

21,140,000

Harish Kuber

2,750,000

Cherylann Pinto

42,940,000

Rajesh Desai

1,200,000

Blanche Saldanha

400,000
As Of  31 Mar 2018